Medical technology company providing devices, services, and therapies across cardiovascular, surgical, neuroscience, and diabetes care.
Profile & Fundamentals
Medtronic: Company identity, ownership, reported financial performance, balance sheets, and corporate actions.
Profile & Fundamentals
Medtronic Profile & Fundamentals
Examine company identity, ownership, reported performance, valuation, balance-sheet resilience, dividends, buybacks, and material corporate events.
Explore this pageJump to a Profile & Fundamentals section
Explore this research
Profile & Fundamentals contents
Jump directly to any section
Company and Market Context
Company Profile & Ownership
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring sys
Company profile record
Medtronic PLC
Common Stock · Health Care · Health Care Equipment
Company
- Company / asset
- Medtronic PLC
- Security type
- Common Stock
- Sector
- Health Care
- Industry
- Health Care Equipment
- HQ
- 🇮🇪 Ireland
- Head office
- Building Two, Galway, Ireland, H91 4K49
Leadership & scale
- Chief executive
- Mr. Geoffrey Straub Martha
- CEO year born
- 1970
- Full-time employees
- 95K
- Fiscal year end
- April
- IPO date
- 1978-01-13
Fundamentals snapshot
- Market Cap
- USD 118.4B
- P/E
- 22.6x
- Revenue (Q3 26)
- USD 9.8B
- Profit (Q3 26)
- USD 1.5B
- Dividend Yield
- 2.2%
- Revenue (FY 26)
- USD 36.4B
- Shares in public float
- 1.3B
- Insider ownership
- 0.39%
Reporting & identifiers
- Symbol
- MDT.NYSE
- Listing
- 🇺🇸 United States | Dividend Tax: 30%
- Ticker Currency
- USD
- Income Statement Currency
- USD
- Balance Sheet Currency
- USD
- Cash Flow Currency
- USD
- EPS Currency
- USD
- Contract Type
- SPOT
- ISIN
- IE00BTN1Y115
- Asset ID
- equity_d573891f-97f3-5a8e-8b19-5db704eef9c9
Ownership
Shares Outstanding
- Shares outstanding
Top holders
- BlackRock Inc113,182,567 shares · 8.85% · Reported 2026-03-31
- Vanguard Capital Management, LLC83,333,833 shares · 6.51% · Reported 2026-03-31
- State Street Corp61,741,014 shares · 4.83% · Reported 2026-03-31
- JPMorgan Chase & Co50,973,541 shares · 3.98% · Reported 2026-03-31
- Vanguard MStar Total Stk Mkt Idx Invest40,879,781 shares · 3.20% · Reported 2026-07-31
- Vanguard 500 Index Investor33,705,113 shares · 2.63% · Reported 2026-07-31
- Vanguard Portfolio Management, LLC33,450,558 shares · 2.62% · Reported 2026-03-31
View more holders (8)
- Geode Capital Management, LLC28,736,341 shares · 2.25% · Reported 2026-03-31
- Arnhold & S. Bleichroeder Advisers, LLC27,567,966 shares · 2.16% · Reported 2026-06-30
- Bank of America Corp26,015,003 shares · 2.03% · Reported 2026-03-31
- Massachusetts Financial Services Company21,437,599 shares · 1.68% · Reported 2026-03-31
- Morgan Stanley - Brokerage Accounts20,717,029 shares · 1.62% · Reported 2026-03-31
- Deutsche Bank AG19,002,414 shares · 1.49% · Reported 2026-03-31
- iShares Core S&P 500 ETF17,096,658 shares · 1.34% · Reported 2026-08-31
- Amvescap Plc.16,786,998 shares · 1.31% · Reported 2026-03-31
Earnings, Profitability & Valuation
Earnings & Revenue
Revenue, Net Income, and Free Cash Flow
- Revenue
- Free cash flow
- Net income
Valuation
Historical P/E Ratio
- Published P/E
Profitability & Margins
Profitability Margins
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
Complete Research Workspace
Unlock the complete Profile & Fundamentals
Sign in to verify your access, or upgrade to the Base plan to open the complete profile & fundamentals and available source data.